CA19-9/Sialyl Lewisa (GI Tumor Marker); Clone 121SLE (Concentrate)

CA19-9/Sialyl Lewisa (GI Tumor Marker); Clone 121SLE (Concentrate)
SKU
SCYRA0397-C.1
Packaging Unit
0,1 ml
Manufacturer
ScyTek Laboratories

Availability: loading...
Price is loading...
Specificity: CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewis a structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewis a and/or Lewis b blood group antigens.
Immunogen: Precipitin lines obtained after immuno-diffusion using monoclonal antibody 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
More Information
SKU SCYRA0397-C.1
Manufacturer ScyTek Laboratories
Manufacturer SKU RA0397-C.1
Package Unit 0,1 ml
Quantity Unit STK
Reactivity Human
Clonality Monoclonal
Isotype IgM
Host Mouse
Product information (PDF) Download
MSDS (PDF) Download